EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Human organoids: Fit for drug discovery?

Annika Wittich, Kim Krieg, Philip Gribbon, Jakob J Metzger, Alessandro Prigione, Ole Pless

Stem Cell Reports · 2026-06 · 21 (6) · 102898

DOI: 10.1016/j.stemcr.2026.102898 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cell Reports, 2026-06. Verfasst von Annika Wittich und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Discovery Research ScreeningPort, 22525 Hamburg, Germany. Hauptthemen laut MEDLINE: Organoids, Drug Discovery. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon Europe, AFM-Téléthon, Deutsches Zentrum fur Luft- und Raumfahrt DLR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Organoids are self-organizing three-dimensional (3D) in vitro tissues derived from pluripotent stem cells (PSCs) that recapitulate key structural and functional features of human organs. Their multicellular architecture and physiological relevance make them promising new approach methodologies (NAMs) for disease modeling, drug discovery, and toxicity testing. However, their reliability and scalability for compound screening remain under evaluation. This review summarizes current human PSC-derived organoid screening strategies, highlighting available readouts, related machine learning methods, and their potential advantages over traditional screening models. We also discuss major challenges, including assay robustness, throughput limitations, and the need for standardized protocols. Advancing validated and scalable approaches will be essential for integrating organoids into pharmaceutical development and improving the translational success of drug candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsDrug DiscoveryHumansPluripotent Stem CellsDrug Evaluation, PreclinicalHigh-Throughput Screening Assays

Stichwörter der Autor:innen

assay developmentdrug discoveryhigh-throughput screeninghit validationhuman pluripotent stem cellsorganoidssmall moleculesthree-dimensional

Autor:innen und Institutionen

  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Discovery Research ScreeningPort, 22525 Hamburg, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Discovery Research ScreeningPort, 22525 Hamburg, Germany; EU-OPENSCREEN, Robert-Rössle-Street 10, 13125 Berlin, Germany.
  • Max Delbrück Center for Molecular Medicine (MDC), Quantitative Stem Cell Biology, 10115 Berlin, Germany.
  • Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Discovery Research ScreeningPort, 22525 Hamburg, Germany. Electronic address: ole.pless@itmp.fraunhofer.de.

Förderung

  • Horizon Europe
  • AFM-Téléthon
  • Deutsches Zentrum fur Luft- und Raumfahrt DLR
  • Deutsche Forschungsgemeinschaft
  • Bundesministerium für Forschung, Technologie und Raumfahrt
  • European Commission

Zitieren

APA

Wittich, A., Krieg, K., Gribbon, P., Metzger, J. J., Prigione, A., & Pless, O. (2026). Human organoids: Fit for drug discovery?. Stem Cell Reports, 21(6), 102898. https://doi.org/10.1016/j.stemcr.2026.102898

Vancouver

Wittich A, Krieg K, Gribbon P, Metzger JJ, Prigione A, Pless O. Human organoids: Fit for drug discovery?. Stem Cell Reports. 2026;21(6):102898. doi:10.1016/j.stemcr.2026.102898

BibTeX
@article{Wittich2026,
  author = {Wittich, Annika and Krieg, Kim and Gribbon, Philip and Metzger, Jakob J and Prigione, Alessandro and Pless, Ole},
  title = {Human organoids: Fit for drug discovery?},
  journal = {Stem Cell Reports},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {102898},
  doi = {10.1016/j.stemcr.2026.102898}
}
Kostenlos starten →